Molecular and Cellular Therapies is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites.

Volume 1, issue 1, December 2013

5 articles in this issue

Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma

Authors (first, second and last of 7)
- Chikako Shibata
- Motoyuki Otsuka
- Kazuhiko Koike
- Content type: Review
- Open Access
- Published: 13 December 2013
- Article: 5
Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration

Authors (first, second and last of 9)
- Marek Malecki
- Chelsea Sabo
- Mark Anderson
- Content type: Research article
- Open Access
- Published: 13 December 2013
- Article: 4
This is part of 1 collection:
Regenerative Medicine
Flowing through the CRISPR-CAScade: Will genome editing boost cell therapies?

Authors
- Uri Ben-David
- Content type: Commentary
- Open Access
- Published: 06 November 2013
- Article: 3
This is part of 1 collection:
Regenerative Medicine
Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?

Authors (first, second and last of 6)
- Babak Jalilian
- Stig Hill Christiansen
- Thomas Vorup-Jensen
- Content type: Review
- Open Access
- Published: 06 November 2013
- Article: 2
Molecular and Cellular Therapies: New challenges and opportunities

Authors
- Xiangdong Wang
- Dan Peer
- Bryon Petersen
- Content type: Editorial
- Open Access
- Published: 06 November 2013
- Article: 1

Volume 1, issue 1, December 2013

Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma

Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration

Flowing through the CRISPR-CAScade: Will genome editing boost cell therapies?

Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?

Molecular and Cellular Therapies: New challenges and opportunities

Explore

Navigation

Volume 1, issue 1, December 2013

Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma

Authors (first, second and last of 7)

Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration

Authors (first, second and last of 9)

Flowing through the CRISPR-CAScade: Will genome editing boost cell therapies?

Authors

Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?

Authors (first, second and last of 6)

Molecular and Cellular Therapies: New challenges and opportunities

Authors

Explore

Search

Navigation